INTRODUCTION
The therapeutic value of blood transfusion is well established and experiences during World War II demonstrated the urgent need for readily available supplies of whole blood. Blood plasma and plasma "substitutes," although effective in combatting shock and in replacing plasma lost into burned and traumatized areas, cannot restore erythrocytes lost from hemorrhage or intravascular destruction ( 1 ) .
Civilian and military experiences have demonstrated the practicability and value of whole blood stored or "banked" in advance of need, and immediately available for use in any emergency. In civilian practice, the blood bank has greatly facilitated the procedure of blood transfusion and has made feasible the routine use of whole blood transfusion. In military practice, banked blood is an absolute essential since it is impractical to bleed donors for transfusion under combat conditions, but it is under these very conditions that whole blood is most urgently needed.
Although stored blood is highly desirable practically and economically, to be effective, the viability of the erythrocytes must be maintained during the period of storage since the major purpose of transfusing whole blood is to supply the recipient with functional erythrocytes. Erythrocytes destroyed immediately after transfusion not only are valueless to the recipient, but the intravascular liberation of large amounts of hemoglobin from 1 The work described in this paper was destroyed cells actually is deleterious and dangerous to the recipient. The life span of the erythrocyte in vivo is between 100 and 120 days but after removal from the circulation the period of viability is greatly reduced. Unless special precautions are observed, blood is unsatisfactory for transfusion purposes after storage for periods as brief as 3 to 5 days (2) .
Attempts to preserve the functional capacity of stored erythrocytes were first made by Rous and Turner in 1916 (3) with considerable success. Robertson, an English army surgeon, using the solution devised by Rous and Turner, made the first successful use of bank blood during the first World War (4) . The solution of Rous and Turner had several serious shortcomings, however, and did not receive general use. During the ensuing 20 years various modifications of the Rous and Turner solution were made and many new types of preservative solutions were devised (5 to 11). None of these preservatives was entirely satisfactory, however, and little exact information was presented as to how effective each actually was in maintaining the viability of the stored cells.
Under the stimulus of World War II various English (12 to 16) and Canadian (17, 18) workers reinvestigated the entire subject of blood preservation, and used as the criterion of effective preservation the post-transfusion survival of erythrocytes determined with the differential agglutinating techniques of Ashby (19) and of Wiener (20) . These agglutinating techniques allow a qualitative comparison of the effectiveness of various preservatives, and also make possible the determination of the total duration of time that transfused cells survive in the recipient's circulation. As usually performed, however, these methods do not permit an accurate quantitative evaluation of the immediate post-transfusion erythrocyte sur- vival; yet it is this immediate survival that is most 687 important in the majority of transfusions. In general, however, the findings and conclusions of the English investigators have been similar or identical to ours which were obtained with a very different, and, we believe, more exact technique.
To determine the most effective method of preserving the viability of erythrocytes in stored blood, we have investigated 16 preservative solutions. We have judged the effectiveness of these solutions from the standpoint of the post-transfusion survival of erythrocytes stored for varying lengths of time in each solution, and we have determined the post-transfusion survival of red blood cells by the radioactively labeled erythrocyte technique previously described by Ross and Chapin (2) . In an attempt to determine which factors in the preservative medium promoted cell survival, extensive studies of the changes in physical and chemical properties of the stored blood were made in conjunction with the survival studies. It soon became apparent to us, as it has to others (21, 22) , that the in vitro characteristics of stored blood are of little value in predicting the suitability of stored blood for transfusions. The really significant criterion of the value of a blood preservative is how well it maintains the viability of the stored erythrocytes, and this attribute can be judged only by studying the survival of the cells after transfusion into a recipient.
PROCEDURES AND METHODS
The radioactively labeled erythrocyte technique of evaluating the survival of erythrocytes following transfusion has been outlined in a previous paper (2) . In brief, this method consists of administering orally or parenterally one of the radioactive isotopes of iron to a prospective blood donor whose hematopoietic system incorporates the radioactive iron in the hemoglobin molecules of newly formed erythrocytes. These erythrocytes are thus "labeled," since once an atom of radioactive iron is built into the hemoglobin molecule it does not exchange with the nonradioactive iron of the plasma or tissues. It remains within the erythrocyte during its lifetime and is liberated from the red cell only when the red cell is destroyed (23 Since the labeling radioactive iron first becomes available to the donor for hemoglobin synthesis at the time of the first injection of the isotope, the maximum age of the donor erythrocytes is determined by the interval of time elapsing between the first injection of radioactive PRESERVATION AND POST-TRANSFUSION SURVIVAL OF STOiED BLOOD iron and the times that the donor is venesected and the blood transfused. Thus, it is possible to state definitely that the labeled cells of a given transfusion have a maximum age of 7 days, 30 days, 100 days, etc. As previously described (2), radioactive iron liberated from destroyed radioactively labeled erythrocytes is rapidly reutilized by the body and incorporated into newly formed hemoglobin and erythrocytes. Therefore, 4 to 6 months after the first injections of radioactive iron the labeled cells are representative of the mixed age population of the whole cell mass. These considerations are important in evaluating the behavior of young, old, and mixed age cells during storage and after transfusion.
With the exception of the previously reported (2) observations on blood stored in tri-sodium citrate solutions the donor erythrocytes used for these studies varied in possible maximum age from 80 days to 120 days. The majority of observations were made on bloods in which the radioactive labeled cells were of all ages and were representative of the age distribution of the entire erythrocyte population.
Technique of collection and storage of radioactively labeled donor blood
After a fasting period of at least 12 hours the donors were bled from an antecubital vein through a closed system into the preservative solution under investigation. Except when noted to the contrary, 400 to 500 ml. of blood were drawn into the preservative solution contained in a 600-ml. pyrex Fenwal transfusion bottle, both solution and container previously having been chilled to 40 C.
The blood was stored immediately in the dark in a stationary mechanical refrigerator thermostatically regulated at 40 to 60 C. until aliquots were removed for transfusion.
Recipients of transfusions
All recipients were normal healthy adult male or female medical students, internes, or hospital technicians. The use of normal individuals excluded the uncontrollable factor of effect of disease processes in the recipient on the post-transfusion survival of erythrocytes. All donors and all recipients used in these studies were of blood group 0. Most of the studies were performed with Rh negative (rh, rh or cde, cde) blood. In experiments in which Rh positive blood was employed, only Rh positive recipients were used. Careful cross-matching with the Landsteiner test tube technique verified complete compatibility between donor and recipient bloods in all cases.
We believe that the use of donor blood of the same blood group as that of the recipient is important in these studies, since it is now well established that the iso-agglutinins contained in transfused blood may destroy the recipient's own erythrocytes (26) . If this should occur following a transfusion of radioactively labeled blood the specific radioactivity of the recipient's erythrocytes would be increased and a false impression of the post-transfusion survival would be obtained.
Techniques of transfusion and sampling of recipients
All transfusions were given early in the morning while the recipient was in a fasting state. The recipient remained in bed during the course of the injection of the blood and for 1 hour thereafter, and then resumed full activity.
Aliquots of radioactively labeled blood for transfusion and for hematologic, chemical, and radioactive studies were removed by aspiration from the storage flasks after the cells and plasma had been gently and thoroughly mixed by rotation. The storage flask was then returned to the refrigerator. Immediately after removal from the storage flask a known amount, usually 100 ml., of the chilled blood was injected into the recipient through a No. 18 needle from a calibrated 100-ml. syringe. Two to 4 minutes were required to make the injection. A known amount of the dye T-1824 was then immediately injected through the same needle into the vein of the recipient for purposes of plasma volume determination.
Samples of blood for hematologic study and for radioactivity and T-1824 concentration determinations were subsequently removed through a No. 18 needle in the opposite arm. A portion of the sample was placed in the mixed oxalate of Heller and Paul (27) for hematologic study, and the remainder of the sample was placed in a calibrated conical centrifuge tube and allowed to clot. The serum from the clotted blood was used for spectroscopic study and for determination of T-1824, hemochromogen, and bilirubin concentrations. The red blood cells from a known volume of oxalated and clotted blood were digested for radioactivity determinations as subsequently described. The exact volume of red blood cells and the amount of hemoglobin in each sample were calculated from the volume of blood and the hematocrit and hemoglobin values determined on an aliquot of this blood.
Ninety transfusions of blood were given in this fashion. There were no reactions of any sort in 88 of the subjects. Two subjects experienced a mild febrile reaction which was proved to be caused by the lot of T-1824 dye solution used for the blood volume determination in these 2 subj ects.
Radioactivity determinations
The specific radioactivity of the donor's and recipient's whole blood, erythrocytes, hemoglobin, and hemoglobin iron was determined with techniques similar to those described by one of us in previous papers (2, 24) , with some modifications (25) . In these experiments we have used the radioactive isotope Fe55 (half life approximately 5 years) instead of the radioactive isotope Fe59 (half life 47 days). The longer half life of Fe55 makes this isotope much more satisfactory than Fe59 for long-term cell tracing experiments. The radiations from Fe55 are low energy x-rays and have necessitated the use of a beryllium window counting tube (25) instead of the thin mica window tube previously used. The preparation of the samples of blood for determination of radioactive con-tent by acid digestion, neutralization, and precipitation of iron is identical with those previously described (24) with the exception that the iron in the present series of experiments was precipitated as ferric hydroxide instead of ferrous sulfide.
To eliminate variation in self-absorption the iron content of each sample was determined by multiplying the grams of hemoglobin in the sample by 0.00334 (that fraction of hemoglobin which is iron) and then enough nonradioactive iron was added to the Sample to make its total iron content 10 mgm.
The iron was electrolytically deposited in a uniform, thin layer on copper discs as previously described (24, 25) , but the plating process was carried out from a ferric rather than a ferrous solution. This required a longer period of electroplating than was the case when a ferrous solution was employed but was satisfactory for quantitative removal of the iron.
An aliquot of the donor blood which had been injected into each subject was assayed for radioactivity with the radioactivity determination of each sample of the recipient's blood, thus eliminating the necessity of making corrections for the decay of the radioactive iron, counting tube variations, etc.
Determination of plasma, blood and erythrocyte volumes
The determination of the post-transfusion survival of erythrocytes by any method is no more accurate than the accuracy with which the total circulating erythrocyte volume of the recipient is determined. This is true not only of the radioactively tagged cell method but also of the Ashby (19) (33, 34) . The disappearance curve was extrapolated to the time of injection.
2. The blood volume and cell volume were calculated from the following formula, employing the corrected hematocrit value previously described (28):
Blood volume = 1 -plasma volume (hematocrit X 0.92)
Cell volume = blood volume -plasma volume.
3. The cell volume so determined was corrected to compensate for the error introduced by unequal distribution of erythrocytes and plasma throughout the vascular system (29) .
Corrected cell volume = cell volume x 0.85. The cell volumes of normal human subjects determined in this fashion compare very closely with the cell volume determined in the same subjects with the use of radioactive tagged cells (31) .
We again wish to emphasize the fact that the use of the cell volume determined in this fashion provides a conservative estimate of post-transfusion erythrocyte survival and allows an accurate comparison of various preservative fluids.
Calculation of post-transfusion survival
The radioactivity present in the circulating red blood cell mass of the recipient was determined at various intervals following the transfusion by applying the formula: 2 ). We have interpreted the decrease in radioactivity as indicating the removal of the non-viable transfused erythrocytes from the recipient's circulation. The rate of this removal was most rapid in those bloods showing the poorest post-transfusion survival. We have interpreted the increase in radioactive iron in the recipient's circulation as indicating the reutilization of the radioactive iron liberated from the destroyed transfused erythrocytes for the formation of new erythrocytes by the recipient. Support is given to this interpretation by observations of similar buildup curves following infusion of solutions of hemoglobin labeled with radioactive iron (35) . During the first 24 hours following the transfusion the amount of radioactive iron incorporated in newly formed recipient's erythrocytes is too small to contribute significantly to the total radioactivity in the recipient's circulation. Therefore, during this period all of the radioactivity in the recipient's blood can be attributed to the presence of surviving labeled donor red blood cells and indicates post-transfusion survival. After 24 hours, the reutilization of radioactive iron and its incorporation in the recipient's own erythrocytes may occur more rapidly than the removal of the transfused labeled cells and may be great enough to indicate a falsely high post-transfusion survival.
Because of these considerations the minimum specific radioactivity of the recipient's erythrocytes, which usually is reached 24 hours after transfusion, has been adopted as indicating the minimum post-transfusion survival of the labeled donor erythrocytes. This minimum survival has been used as the criterion for evaluating the effectiveness of the blood preservative under consideration.
Preservative fluids studied
All solutions (except the corn syrup and Alsever's solutions which were obtained commercially) were prepared with pyrogen-free, freshly distilled water and reagent chemicals. All glassware and storage bottles (except the Baxter bottles containing Alsever's solution) were pyrex glass. With the exception of a few experiments that were carried out at room temperature, all bloods were drawn into containers and solutions which previously had been chilled to 40 C. and were immedately stored at 40 to 60 C.
The fluids studied may be grouped into those used for the preservation of whole blood and those used for the preservation of erythrocytes separated from blood plasma. A description of the constitution, the methods of preparation, and use of these fluids follows. The separated cells for solutions 7, 8, 9, and 10 were prepared as follows: 450 ml. of donor blood were drawn into 50 ml. of previously chilled 2.5 per cent trisodium citrate solution of pH 7.5. The cells were immediately sedimented by centrifugation at 2,500 r.p.m. for 1 hour, and the plasma then removed by aspiration with aseptic precautions. For the experiments with solutions 11, and 12, 400 ml. of blood were drawn into 100 ml. of 2 per cent disodium citrate solution of pH 5.0. Centrifugation and separation of plasma were carried out as previously described. The cell mass for solution 13 was obtained from defibrinated blood which was centrifuged and separated from its plasma as described above.
A Seven transfusions of these cells were given after storage for 6 to 22 days. 5 The human albumin used in this solution was provided through the courtesy of Dr. Edwin Cohn of the Harvard Medical School.
Solutions No. 9, 10, 11, and 12: Maltose-dextrose solutions 
Hematologic studies
The following studies were performed on aliquots of donor blood shortly after it was drawn into the preservative solution and at intervals during the period of stor-age; they were also performed on aliquots of the samples removed from the recipients before and after the transfusion:
1. Erythrocyte and leukocyte counts were performed in quadruplicate, using 4 pipettes and 4 counting chambers and the average of the 4 counts was used in calculations.
2. Hematocrit determinations were made with the Wintrobe hematocrit tube and with application of a relative centrifugal force of 1,800 for 1 hour.
3. Whole blood hemoglobin concentration was determined by the Evelyn oxyhemoglobin method (38) on the Evelyn photoelectric colorimeter.
4. Erythrocyte indices were calculated according to the method of Wintrobe (39).
5. The concentration of heme pigments in the plasma of the recipient and in the supernatant plasma of the donor blood was determined according to the hemochromogen method of Flink and Watson (40) .
6. The plasma bilirubin concentrations of the recipient were determined according to the method of Evelyn and Malloy (41) .
7. The whole blood sugar content of the donor blood was determined by the method of Folin and Malmros (42) . 8 . The pH of the donor blood was determined with the Beckman glass electrode pH meter.
9. The susceptibility of the donor erythrocytes to hemolysis by hypotonic saline solutions ("osmotic fragility") was determined by the method originally suggested by Dacie and Vaughan (43) as modified by Shen, Ham, and Fleming (44) .
10. The morphologic characteristics of the donor erythrocytes were observed in wet unstained preparation and in dry Wright stained preparations.
11. Spectroscopic studies were performed on plasma and serum of donor and recipient bloods with the Zeiss hand spectroscope and the Hartridge reversion spectroscope. The majority of the non-viable cells are removed during the first hour or 2 following transfusion and the survival curve then continues to fall more gradually during the next 18 to 20 hours. At the end of 24 hours the minimum post-transfusion survival usually is reached. It is this minimum survival which we have used as the criterion of the effectiveness of the blood preservative, and it is this value which has been used in constructing the curves in Figure 4 . After 24 hours newly formed erythrocytes containing reutilized radioactive iron may be liberated in the recipient's circulation more rapidly than the labeled donor cells are removed and consequently the concentration of radioactive iron per unit volume of red cells increases.
Trisodium citrate obviously is a very poor blood preservative (Figure 1) . The erythrocytes of stored citrated blood degenerated at a rate of 7 per cent per day and after storage for 7 days only 50 per cent of the transfused cells survived 24 hours (Figures 1 and 4) . If we accept as an arbitrary minimum requirement for a satisfactory transfusion the survival of 70 per cent of the transfused cells for at least 24 hours following transfusion, citrated blood can no longer be considered satisfactory for transfusion if stored for longer than 5 days.
Denstedt's solution, in marked contrast to trisodium citrate, is an excellent blood preservative (Figures 2 and 4 ). Blood stored in this solution for 24 days showed satisfactory post-transfusion survival, and the rate of degeneration of red cells during storage was only approximately 1.4 per cent per day. There was 1 serious drawback to Denstedt's solution, however. The necessity for separately autoclaving the citrate, dextrose, and phosphate solutions and then mixing them with sterile technique made its preparation exceedingly laborious and not very satisfactory for routine use. Since the acid citrate-dextrose solution (solution No. 5) was found to have almost identical preservative powers and was much simpler to prepare, Denstedt's solution does not justify the effort required to prepare it. The 2 Alsever's solutions studied differed only in their citric acid content and initial pH, and were almost identical in their preservative powers (Figure 3 ). They were not good preservative solutions, since after storage for only 7 days, less than 70 per cent of the transfused cells survived 24 hours, and the rate of degeneration of the erythrocytes during storage amounted to approximately 3 per cent per day.
Another serious disadvantage of Alsever's solution is the large volume of diluent (500 ml.) required for the preservation of 500 ml. of blood. The addition of this large volume of fluid serves no useful purpose and is actually contraindicated in many blood transfusions.
The most satisfactory blood preservatives which we studied were the acid citrate-dextrose solutions, either the solution originally described by Loutit and Mollison (14) 6, 14, 15, and 16 ). The acid citrate-dextrose solution of Loutit and Mollison (for convenience called "ACD" throughout the remainder of this paper) was an excellent blood preservative-maintaining satisfactory transfusion properties in blood stored for as long as 23 days (Figure 4) (Table II) . Preservation of erythrocytes separated from plasma Since normal blood contains various hemolytic systems it was believed that erythrocytes might survive better in vitro if they could be removed from their plasma and resuspended in some other fluid. Furthermore, if some method of preserving cells separated from plasma could be devised it would salvage tremendous quantities of red blood cells which are discarded in the process of preparing blood plasma and plasma fractions. Such studies were successful in demonstrating a simple yet effective method of preserving red blood cells after separation from plasma.
The studies of Furchgott and Ponder (45) indicated that crystalbumin prevented the development of certain morphologic abnormalities in erythrocytes placed under abnormal conditions in vitro. With the hope that human albumin might exert a similar beneficial effect on stored human red cells, we resuspended erythrocytes separated from whole blood in solution No. 7. After storage for 22 days 70 per cent of the transfused cells survived 24 hours ( Figure 5 ), which is good preservation but no better than in several far simpler and less expensive solutions.
This proved to be the case with corn syrup (solution No. 8) which was investigated at the request of the Subcommittee on Blood Substitutes. It maintained satisfactory transfusion properties in resuspended erythrocytes for only 10 days ( Figure 5 ).
In vitro studies indicated that non-diffusible disaccharides might be effective as erythrocyte preservatives; so the maltose-dextrose solutions (solutions No. 9, 10, 11 and 12) were devised to test this possibility. Only solution No. 12 was of any value (Table III) .
Ball and his collaborators (37) showed that the malarial parasite could be satisfactorily cultivated in erythrocytes suspended in the complex solution described as "RPA" (solution No. 13). It seemed possible that one of the reasons this solution supported the growth of malarial parasites was because it maintained erythrocyte viability. Therefore, we investigated the preservation of erythrocytes separated from their plasma, resuspended, and stored in this fluid. The post-transfusion survival of these cells was quite good (Table III) , but, as in the case of the albumin solution, corn syrup, and maltose-dextrose solutions, it was not so good as the survival of cells stored in simpler and less expensive preservatives.
The excellence and simplicity of the ACD solutions (solutions No. 5 and 6) as whole blood preservatives and the fact that plasma was not (3) in their original observations clearly demonstrated the importance of refrigeration in the preservation of stored blood, a recent publication questioned its necessity and claimed that certain preservatives were capable of maintaining erythrocyte viability at room temperature (46) . Large amounts of unrefrigerated whole blood were being sent to the European Theatre of Operations in 1944, and since poor preservation of this blood might render it potentially dangerous to recipients the question of refrigeration was reinvestigated.
In the first series of observations, donor blood was drawn directly into Alsever's solution (solution No. 4) at room temperature (250 C.) and allowed to remain at room temperature until transfused. As illustrated in Figure 7 the post-transfusion survival of these erythrocytes was extremely poor. After 2 days' storage only 65 per cent of erythrocytes survived 24 hours in the recipient's circulation, and after 4 days, only 25 per cent of the cells survived 24 hours.
When blood was taken into chilled ACD, stored at 40 C. for 3.5 days, and then at room temperature (250 C.) until transfusion, erythrocyte survival was extremely poor, and after 9 days' storage, none of the labeled cells survived (Figure 7) .
The adverse effect of warm temperature was not overcome by returning the blood to refrigeration after it had been exposed for relatively brief pe- These studies emphasize the necessity for constant refrigeration of whole blood and of erythrocytes during storage and reconfirm the original observations of Rous and Turner. were completely satisfactory, and the incidence of reactions was not higher than that usually prevailing in this blood bank. The concentration of the citrate ion in the supernatant plasma of the ACD blood mixture is approximately 24 millimolars-a value approximately double the concentration needed to prevent coagulation (47) . In spite of this fact, however, there is a tendency to clot formation in blood drawn into this solution unless the blood and anticoagulant are thoroughly mixed during the process, of venesection. If this precaution is observed, the incidence of clot formation is no higher than with other preservative fluids, and in our experience has presented no serious difficulty.
From January, 1946 to February, 1947 the 50 ml. of 5 per cent ACD solution (solution No. 15) was used for routine bleedings; 2,522 bloods were drawn into this solution, 2,002 transfusions were dispensed, and 181 pints of frozen plasma were prepared. This preservative was in every respect as satisfactory as the larger volume ACD preservative.
Packed red blood cells separated from their plasma were routinely prepared from bloods drawn into each solution as described for solutions No. 14 and 15. They have proven eminently satisfactory therapeutically, and their use in transfusions for the correction of anemia is steadily increasing.
COM MENT
Loss of viability of stored erythrocytes proceeds at a very constant rate in blood stored in any given preservative, suggesting that the degenerative process may be one of aging and similar to the process normally going on in the body. The steadiness of the rate of senescence is well illustrated in Figures   4 , 5, and 7 in which it appears that the decrease in viable erythrocytes is a straight line function of time. It is possible to calculate the approximate rate of senescence per day for blood stored in different preservatives and such rates are tabulated in Table IV . The rate is high in poor preservatives and at room temperature, and low in good preservatives and in the cold. In all preservatives studied it is higher than the 0.83 to 1.0 per cent per day rate of degeneration of erythrocytes in the body.
Following injection into a recipient, most of the non-viable erythrocytes are removed from the circulation very rapidly-usually within an hour or two. A smaller number are removed at a less rapid rate during the next 10 to 20 hours ( Figures  1 and 2 ). The cells which are removed rapidly 700 The longer a blood has been stored and the more non-viable erythrocytes there are-the more rapid is the rate at which the non-viable cells are removed. This may be accounted for by progressive changes in the stored erythrocytes after they have become non-viable-a "postmortem degeneration," so to speak. If these changes are extensive enough they may result in actual disintegration of the erythrocytes and be reflected by gross hemolysis in the stored blood. As described in a subsequent paper, however, extensive degenerative changes may occur in erythrocytes stored in some preservatives, without gross hemolysis or other evidence of cell disintegration.
Our studies have been directed primarily at a critical evaluation of the effectiveness of certain selected preservatives, rather than at a general survey of the properties of preservative fluids. However, there are certain important features of blood preservatives which have become apparent in our studies, and these will be commented on briefly. The presence of dextrose in a preservative solution is essential for maintenance of erythrocyte viability. Its actual concentration does not appear to be critical within the range of 0.5 to 2.0 per cent. The initial reaction of the preservative-blood mixture is important and should be between pH 6.8 and 7.0. Certain autolytic or destructive processes probably are retarded at this pH. The degree of dilution of the blood with preservative fluid is not of great importance. The survival of erythrocytes stored in a cell mass with a hematocrit of 88 per cent is little different from the survival of cells stored in a whole blood-preservative mixture with a hematocrit of 30 per cent. The presence of plasma in the preserving medium is not essential for good erythrocyte preservation, and there is some evidence that its removal may improve preservation. The importance of constant refrigeration has already been emphasized. The addition of vitamins, amino acids, and other accessory substances is not essential and does not improve erythrocyte preservation.
In adopting the arbitrary value of 70 per cent post-transfusion survival as a minimum requirement for satisfactory transfusion properties, we do not wish to imply that blood providing cells of this viability is as satisfactory as blood in which a greater percentage or all of the cells are viable. Although blood stored for 3 weeks and providing erythrocytes of 70 per cent viability may be "satisfactory" for transfusion under emergency circumstances, it is not so good as fresh blood or blood stored for a shorter period of time. During the war when large quantities of blood had to be shipped literally to the ends of the earth it was occasionally necessary to use blood stored for 3 weeks, and such blood saved the lives of thousands of American troops. In civilian practice and in most hospital blood banks there is no necessity for using blood stored this long.
From a practical standpoint, however, transfusion of blood stored in ACD, or one of the modifications of ACD, for 7 to 10 days may be considered as satisfactory as fresh blood for the relief of (2) The most effective preservative and the simplest to prepare was an acid citrate-dextrose solution.
(3) Whole blood drawn into this solution maintained satisfactory transfusion properties during a storage period of 21 days.
(4) Erythrocytes separated from blood drawn into this acid citrate-dextrose solution and stored without addition of diluent also maintained satisfactory transfusion properties during a storage period of 21 days.
(5) This acid citrate-dextrose solution proved to be very satisfactory in routine hospital blood bank use.
(6) Studies of the influence of temperature on the viability of stored erythrocytes emphasized the necessity for constant refrigeration of blood during the entire period of storage.
